World's first digital hospital on its way as Medbelle raises €6 million in funding

Charlie Spargo's picture
Medbelle's founders

London-based MedTech startup Medbelle has raised €6 million in a Series A funding round to support it on its journey to create a fully end-to-end medical platform.

The round was led by Signals Venture Capital, part of German health insurer Signal Iduna, with concurrent investment from Talis Capital, Mutschler Ventures, IBB and Cavalry Ventures.

Medbelle was founded in 2016 by Leander de Laporte and Daniel Kolb, offering an app and digital platform to provide comprehensive information about treatments, prices, financing options, consultations, medical details, and appointments. Medbelle aims to support patients from the very first moment they engage a healthcare provider all the way to the end of aftercare. They use a three-layered ‘digital hospital’ model to do so.

The €6 million raised will allow Medbelle - which has already been used by 30,000 Brits - to start its next stage of rollout. Currently it only operates within private healthcare and focuses on cosmetics, bariatrics, and ophthalmology, with future expansion into orthopaedics and fertility planned.

“The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint,” said Daniel Kolb, Co-founder and MD.

“It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”

Signals Venture Capital investment manager Clemens Koós said: “Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now.

“Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments - while allowing healthcare providers to efficiently focus on treating patients."